Novel Therapies for Essential Tremor

US Department of Veterans Affairs (VA)

Status and phase: Completed; Phase 3

Conditions: Essential Tremor

Treatments: Drug: treatments for essential tremor

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT00018564

NEUD-048-00S

Details and patient eligibility

About

This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.

Full description

Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

1. Diagnosis of essential tremor.
2. Tremor rating scale score 3 or one or both upper extremities
3. Unsatisfactory response to primidone or to propanolol
4. Not taking tremor-inducing drug
5. Able to comply with visits